SEC Form D · Amendment · filed January 12, 2023
Transposon Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Eckard R. Weber, Md · San Diego, CAExec · DirectorKeith A. Katkin · San Diego, CADirectorDennis T. Podlesak · San Diego, CADirectorWilliam R. Harrington, Md, Mba · San Diego, CADirectorBrent R. Ahrens · San Diego, CADirectorJohn R. Pacifico · San Diego, CADirectorDaniel R. Hetu, Md, Mba · San Diego, CADirectorLynne R. Rollins · San Diego, CAExecBrian T. Slingsby, Md, Phd, Mph · San Diego, CADirectorKimberly Zaccagnino · New York, NYDirectorJames Babcock · New York, NYDirectorGarret J. Hrncir · Menomonee Falls, WIExec · DirectorPatrick Hardiman · New York, NYDirectorMark Affolter · New York, NYDirectorEdward Martinson · New York, NYDirectorPaul Cho · Los Angeles, CAExecBrian Steiner · New York, NYDirectorAdam Glick · New York, NYDirectorBruce Clarke · Dallas, TXDirectorJukka Heikka · Dallas, TXExecMaia Heymann · Dallas, TXDirectorKarl Sowa · Dallas, TXDirectorCharlotte Gummesson · Toronto, Ontario, CanadaDirectorIvan Koon · Dallas, TXExec · DirectorEmi Quadri · Toronto, Ontario, CanadaDirectorHayfin Capital Management LLP · London, United KingdomDirectorBrock F. Smith · Boca Raton, FLDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗